346 related articles for article (PubMed ID: 16755289)
21. Trends in melanoma in the elderly in Denmark, 1980-2012.
Hoejberg L; Gad D; Gyldenkerne N; Bastholt L;
Acta Oncol; 2016; 55 Suppl 1():52-8. PubMed ID: 26785326
[TBL] [Abstract][Full Text] [Related]
22. Variation in incidence of breast, lung and cervical cancer and malignant melanoma of skin by socioeconomic group in England.
Shack L; Jordan C; Thomson CS; Mak V; Møller H;
BMC Cancer; 2008 Sep; 8():271. PubMed ID: 18822122
[TBL] [Abstract][Full Text] [Related]
23. Cutaneous melanoma.
Armstrong BK; Kricker A
Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
[TBL] [Abstract][Full Text] [Related]
24. Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999.
Ulmer MJ; Tonita JM; Hull PR
J Cutan Med Surg; 2003; 7(6):433-42. PubMed ID: 15926213
[TBL] [Abstract][Full Text] [Related]
25. Trends in incidence and survival of cutaneous malignant melanoma in Estonia: a population-based study.
Padrik P; Valter A; Valter E; Baburin A; Innos K
Acta Oncol; 2017 Jan; 56(1):52-58. PubMed ID: 27796149
[TBL] [Abstract][Full Text] [Related]
26. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
27. The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
Chellini E; Crocetti E; Carli P; Martini A; Giovannetti L
Melanoma Res; 2007 Apr; 17(2):129-30. PubMed ID: 17496788
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
[TBL] [Abstract][Full Text] [Related]
29. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
Hollestein LM; van den Akker SA; Nijsten T; Karim-Kos HE; Coebergh JW; de Vries E
Ann Oncol; 2012 Feb; 23(2):524-30. PubMed ID: 21543630
[TBL] [Abstract][Full Text] [Related]
30. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
31. Malignant melanoma in Scotland 1979-1983.
MacKie RM; Smyth JF; Soutar DS; Calman KC; Watson AC; Hunter JA; McLaren KM; MacGillivray JB; McPhie JL; Rankin R
Lancet; 1985 Oct; 2(8460):859-63. PubMed ID: 2864579
[TBL] [Abstract][Full Text] [Related]
32. The burden of malignant melanoma--lessons to be learned from Austria.
Monshi B; Vujic M; Kivaranovic D; Sesti A; Oberaigner W; Vujic I; Ortiz-Urda S; Posch C; Feichtinger H; Hackl M; Rappersberger K
Eur J Cancer; 2016 Mar; 56():45-53. PubMed ID: 26802530
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous malignant melanoma--clinical epidemiology and survival.
Nair MK; Varghese C; Mahadevan S; Cherian T; Joseph F
J Indian Med Assoc; 1998 Jan; 96(1):19-20, 28. PubMed ID: 9601186
[TBL] [Abstract][Full Text] [Related]
34. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.
Stang A; Valiukeviciene S; Aleknaviciene B; Kurtinaitis J
Eur J Cancer; 2006 Mar; 42(5):660-7. PubMed ID: 16510281
[TBL] [Abstract][Full Text] [Related]
35. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
36. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
37. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study.
MacKie RM; Bray CA; Hole DJ; Morris A; Nicolson M; Evans A; Doherty V; Vestey J;
Lancet; 2002 Aug; 360(9333):587-91. PubMed ID: 12241928
[TBL] [Abstract][Full Text] [Related]
38. Ten-year audit of melanoma in a central England population.
Hardwicke J; Brunt AM; Rylands G; Rayatt S
Acta Derm Venereol; 2011 Jun; 91(4):440-3. PubMed ID: 21336477
[TBL] [Abstract][Full Text] [Related]
39. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
40. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
